Business
Currency:CNY
2023/FY
Stock NameRevenueRatio
销售眼科产品204.7M83.09%
医药产品推广服务38.35M15.57%
以销售为基础的特许权使用费收入3.05M1.24%
合约开发及生产服务271K0.11%
Product
No Data
Region
No Data